Skip to main content
OpenTrials
Completed

NCT Number: NCT06663241

The Validation of New Photographic Technology for Assessing Skin Lesions

The purpose of this study is to determine the validity of a new photographic technology in a dermatologic setting. The digital picture uses high levels of resolution to look at skin biopsy lesions. These photos will be compared to current standard-of-care with hematoxylin and eosin histologic analysis by board-certified dermatologists.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Wright State Physicians

Fairborn, Ohio, 45324, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients ages 18 and older.
  • Able to comprehend procedures, risks, and informed consent.
  • Have a skin lesion the practitioner believes, and subject agrees, should be biopsied.
  • Lesion on a non-revealing part of the body (none on areas that would be recognizable, nor on groin nor breasts).
  • Willingness of subject to share the results of the biopsy pathology.

Exclusion criteria

  • Lesion on a revealing part of body.
  • Unable to understand the procedures, informed consent.

Treatment and study plan

Primary outcomes

  1. Number of matching dermatologic diagnoses from photography to biopsied lesions.

    Time frame: At time of biopsy procedure of the lesion.

    A group of board-certified dermatologists will evaluate the standard digital vs. enhanced digital photograph of the lesion to compare the accuracy of diagnoses to the pathology report, with pathology serving as the gold standard.

Sponsors and collaborators

Lead sponsor

Wright State University

Other

Registry information

Official study title

Validation of New Photographic Technology for Assessing Skin Lesions

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Oct 29, 2024
Registry last updated
Feb 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.